A New Objective Titration Procedure for the Treatment of Mandibular Advancement Device in OSAHS Patients
A New Objective Titration Procedure Using Remotely Intelligent Sleep Monitoring System for the Treatment of Mandibular Advancement Device in OSAHS Patients
Beijing Jishuitan Hospital
60 participants
Apr 25, 2024
INTERVENTIONAL
Conditions
Summary
The aim of this clinical trial is to apply a new objective titration procedure in obstructive sleep apnea hypopnea syndrome (OSAHS) patients treated with mandibular advancement device (MAD), and to compare this new objective titration procedure with the subjective titration procedure which is commonly used in clinical practice. The remotely intelligent sleep monitoring system (RISMS) will be used in the new objective titration procedure. The main questions it aims to answer are: 1. The efficacy of MAD therapy after each titration procedure. 2. The titration time efficiency and the improvement of subjective symptoms after each titration procedure.
Eligibility
Inclusion Criteria5
- OSAHS patients with AHI≥15
- ≤age≤70 years;
- Subject is capable of giving informed consent
- refusal of or noncompliance with CPAP (continuous positive airway pressure) or unwilling to undergo upper airway surgery
- Normal clinical, periodontal and temporomandibular joint examination
Exclusion Criteria5
- Active periodontal problems including tooth mobility
- active temporomandibular joint dysfunction
- Edentulous patients or Insufficient teeth to support MAD
- patients with severe unstable systemic diseases or suffering from psychiatric disorders
- Enlarged palatine tonsils (Friedman grade IV tonsils)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The OSAHS patients referred for MAD treatment will experience either the objective titration procedure or the subjective titration procedure.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06424405